James A. Linn
Research Triangle Park
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James A. Linn.
Tetrahedron Letters | 1997
David H. Drewry; Samuel W. Gerritz; James A. Linn
Abstract The solid-phase synthesis of trisubsituted guanidines is reported via aza-Wittig coupling of a solid-supported alkyl iminophosphorane with an aryl or alkyl isothiocyanate to generate the corresponding solid-supported carbodiimide which is then reacted with a primary or secondary amine to afford the desired trisubstituted guanidines.
Bioorganic & Medicinal Chemistry Letters | 2009
Kyle Allen Emmitte; C. Webb Andrews; Jennifer Gabriel Badiang; Ronda G. Davis-Ward; Hamilton D. Dickson; David H. Drewry; Holly Kathleen Emerson; Andrea H. Epperly; Daniel F. Hassler; Victoria B. Knick; Kevin Wayne Kuntz; Timothy J. Lansing; James A. Linn; Robert A. Mook; Kristen E. Nailor; James Michael Salovich; Glenn M. Spehar; Mui Cheung
The discovery and development of a series of thiophenes as potent and selective inhibitors of PLK is described. Identification and characterization of 2, a useful in vitro PLK inhibitor tool compound, is also presented.
Tetrahedron Letters | 2003
Hari S. Patel; James A. Linn; David H. Drewry; Daniel A. Hillesheim; William J. Zuercher; William J. Hoekstra
Constrained triarenes have been important templates for selective modulation of the estrogen receptor (ER). For our ER program, we sought an unexplored, synthetically accessible heterocyclic template capable of bearing a broad range of pharmacophores. Traditional approaches to these therapeutics such as raloxifene have relied on an alkoxy moiety to link the arene-based scaffold to the modulating amine group. Alternatively, aryl halide-mediated introduction of alkylene or aryl side chains has not been studied extensively. The synthetic incorporation of pharmacophoric side chains that are carbon-linked to a novel imidazopyridine-based ER recognition motif is disclosed.
European Journal of Medicinal Chemistry | 1990
James L. Kelley; James A. Linn; J. W. T. Selway
Abstract To evaluate the effect of different 6-substituents on antirhinoviral activity, a series of 6-substituted-9-(4-methylbenzyl)-2-trifluoromethyl-9 H -purines was synthesized and tested. A matrix map of space adjacent to the 6-position was constructed to facilitate structure—activity analysis. This study provided evidence that a lipophilic pocket exists on the virus capsid surface, which accomodates the methyl group of the 6-methylaminopurines.
Journal of The Chemical Society, Chemical Communications | 1994
James A. Linn; Ed W. McLean; James L. Kelley
2-Amino-9-benzyl-6-chloro-9H-purine 1 is hydrolysed in refluxing water in the presence of 1,4-diazabicyclo[2.2.2]octane (DABCO) to give 2-amino-9-benzyl-1,6-dihydro-6-oxo-9H-purine 3; however, 1 reacts with hydroxide ion at ambient temp., or analcohol and potassium carbonate at elevated temperatures, in the presence of DABCO togive 3 or 6-alkoxy-2-amino-9-benzyl-9H-purines 4–8, respectively.
Tetrahedron Letters | 1999
James A. Linn; Samuel W. Gerritz; Anthony L. Handlon; Clifton E. Hyman; Dennis Heyer
Abstract The solid phase synthesis of 1,3,5-trisubsituted pyridin-2-ones is reported via selective 1 NH- alkylation of 3-amino-5-carbomethoxy-1 H -pyridin-2-one with a solid-supported halo-acid. Coupling of an acid to solid-supported 3-aminopyridinone was followed by saponification of the methyl ester to give the acid. Activation of the acid via the pentafluorophenyl ester allowed reaction with an amine, and cleavage from the solid support with TFA:H 2 O (95:5) provided 1,3,5-trisubstituted pyridin-2-ones.
European Journal of Medicinal Chemistry | 1990
James L. Kelley; James A. Linn; R. G. Davis; J. W. T. Selway
Abstract A series of 6-(3-fluoroanilino)-9-(substituted-benzyl)-2-trifluoromethylpurines was synthesized and tested for antirhinovirus activity. Most of the compounds were prepared by alkylation of a 6-anilino-2-trifluoromethylpurine with a benzyl halide or by amination of a 6-chloro-9-benzylpurine with an aniline. Compounds with a variety of para -benzyl substituents had activity against rhinovirus serotype 1B. The 6-(3-fluoroanilino)-9-(3-fluorobenzyl)-2-trifluoromethylpurine 15 had good activity (IC 50 s = 0.4–13 μM) against 80% of the 47 serotypes tested, but pharmacokinetic studies indicated poor oral bioavailability.
Nucleosides, Nucleotides & Nucleic Acids | 1989
James L. Kelley; James A. Linn; Lilia M. Beauchamp; Peter Collins; J. W. T. Selway; Karen K. Biron; Howard J. Schaeffer
Abstract The synthesis and antiherpetic activity of 9-[[[2-hydroxy-1-(hydroxymethyl)ethyl]thio]methy1]guanine (4) and 1-[[[2-hydroxy-1-(hydroxymethyl)ethyl]thio]methy]cytosine (6), the side-chain thio analogues of ganciclovir (3) and BW A1117U (5), are described. The sidechain synthon 1,3-bis(benzyloxy)-2-[(chloromethyl)thio]propane (11) was prepared in four steps from 1,3-bis(benzyloxy)-2-propanol (7). Alkylation of 2-amino-6-chloro-9H-purine with 11 provided the intermediate 9-substituted-2-amino-6-chloropurine 12, which was conveniently converted to 4 in two steps. Reaction of a fivefold excess of cytosine with 11 provided the desired 1-isomer 14, which was debenzylated to give 6. In contrast with ganciclovir (3) and BW A1117U (5), neither 4 nor 6 had significant in vitro activity against human cytomegalovirus.
Nucleosides, Nucleotides & Nucleic Acids | 1993
James A. Linn; James L. Kelley
Abstract Two C-1′-branched acyclic thymine derivatives, 1-[2-hydroxy-1-(2-hydroxyethoxy)ethyl]thymine and 1-[3-hydroxy-1-(2-hydroxyethoxy)-propyl]thymine were synthesized by a novel iodine-activated reaction of a tolylthio derivative with ethylene glycol. This synthetic method provides a potentially versatile synthetic entry to C-1′-branched acyclic nucleosides.
Journal of Medicinal Chemistry | 1988
James L. Kelley; Mark P. Krochmal; James A. Linn; Ed W. McLean; Francis E. Soroko